Inhibitors of BRD4 Protein from a Marine-Derived Fungus Alternaria sp. NH-F6
- PMID: 28300771
- PMCID: PMC5367033
- DOI: 10.3390/md15030076
Inhibitors of BRD4 Protein from a Marine-Derived Fungus Alternaria sp. NH-F6
Abstract
Bromodomains (BRD) are readers of the epigenetic code that regulate gene transcription through their recognition of acetyl-lysine modified histone tails. Recently, bromodomain-containing proteins such as BRD4 have been demonstrated to be druggable through the discovery of potent inhibitors. These protein-protein interaction inhibitors have the potential to modulate multiple diseases by their profound anti-inflammatory and antiproliferative effects. In order to explore new BRD4 inhibitors as well as lead compounds for the development of new drugs, the secondary metabolites of Alternaria sp. NH-F6, a fungus isolated from deep-sea sediment samples, were analyzed systematically. Five new compounds including two new perylenequinones (1-2), one new alternaric acid (3), 2-(N-vinylacetamide)-4-hydroxymethyl-3-ene-butyrolactone (4), one new cerebroside (5), together with 19 known compounds (6-24) were isolated from the ethyl acetate extracts of this strain. Their structures were elucidated using nuclear magnetic resonance (NMR) and high resolution electrospray ionization mass spectrometry (HR-ESI-MS) analyses. Finally, all these compounds were evaluated for their inhibitory activity against BRD4 protein, and compound 2 exhibited a potent inhibition rate of 88.1% at a concentration of 10 µM. This research provides a new BRD4 inhibitor which may possess potential antitumoral, antiviral, or anti-inflammatory pharmaceutical values.
Keywords: Alternaria sp. NH-F6; marine-derived fungus; secondary metabolites.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
), 1H-1H COSY (
) and NOESY (
) correlations of compound 1.
), 1H-1H COSY (
) and NOESY (
) correlations of compound 2.
) and 1H-1H COSY (
) correlations of compound 3.
) and 1H-1H COSY (
) correlations of compound 4.
) and 1H-1H COSY (
) correlations of compound 5.Similar articles
-
Anti-Phytopathogenic and Cytotoxic Activities of Crude Extracts and Secondary Metabolites of Marine-Derived Fungi.Mar Drugs. 2018 Jan 18;16(1):36. doi: 10.3390/md16010036. Mar Drugs. 2018. PMID: 29346329 Free PMC article.
-
Perylenequione Derivatives with Anticancer Activities Isolated from the Marine Sponge-Derived Fungus, Alternaria sp. SCSIO41014.Mar Drugs. 2018 Aug 14;16(8):280. doi: 10.3390/md16080280. Mar Drugs. 2018. PMID: 30110969 Free PMC article.
-
Identification and Bioactivity of Compounds from the Mangrove Endophytic Fungus Alternaria sp.Mar Drugs. 2015 Jul 20;13(7):4492-504. doi: 10.3390/md13074492. Mar Drugs. 2015. PMID: 26204946 Free PMC article.
-
Bioactive terpenes from marine-derived fungi.Mar Drugs. 2015 Apr 3;13(4):1966-92. doi: 10.3390/md13041966. Mar Drugs. 2015. PMID: 25854644 Free PMC article. Review.
-
A Review Study on Macrolides Isolated from Cyanobacteria.Mar Drugs. 2017 Apr 26;15(5):126. doi: 10.3390/md15050126. Mar Drugs. 2017. PMID: 28445442 Free PMC article. Review.
Cited by
-
Targeting Epigenetic 'Readers' with Natural Compounds for Cancer Interception.J Cancer Prev. 2020 Dec 30;25(4):189-203. doi: 10.15430/JCP.2020.25.4.189. J Cancer Prev. 2020. PMID: 33409252 Free PMC article. Review.
-
Novel Natural Products from Extremophilic Fungi.Mar Drugs. 2018 Jun 4;16(6):194. doi: 10.3390/md16060194. Mar Drugs. 2018. PMID: 29867059 Free PMC article. Review.
-
Glycosylated Natural Products From Marine Microbes.Front Chem. 2020 Jan 10;7:879. doi: 10.3389/fchem.2019.00879. eCollection 2019. Front Chem. 2020. PMID: 31998682 Free PMC article. Review.
-
Cytotoxic Potential of Alternaria tenuissima AUMC14342 Mycoendophyte Extract: A Study Combined with LC-MS/MS Metabolic Profiling and Molecular Docking Simulation.Curr Issues Mol Biol. 2022 Oct 20;44(10):5067-5085. doi: 10.3390/cimb44100344. Curr Issues Mol Biol. 2022. PMID: 36286059 Free PMC article.
-
Secondary metabolites of Alternaria: A comprehensive review of chemical diversity and pharmacological properties.Front Microbiol. 2023 Jan 6;13:1085666. doi: 10.3389/fmicb.2022.1085666. eCollection 2022. Front Microbiol. 2023. PMID: 36687635 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
